Lin, T., Zhang, Y., Wei, Q., & Huang, Z. (2024). GLP‐1 receptor agonist liraglutide alleviates kidney injury by regulating nuclear translocation of NRF2 in diabetic nephropathy. Clinical & Experimental Pharmacology & Physiology, 51(12), 1. https://doi.org/10.1111/1440-1681.70003
Chicago Style (17th ed.) CitationLin, Tingting, Yuze Zhang, Qifeng Wei, and Zugui Huang. "GLP‐1 Receptor Agonist Liraglutide Alleviates Kidney Injury by Regulating Nuclear Translocation of NRF2 in Diabetic Nephropathy." Clinical & Experimental Pharmacology & Physiology 51, no. 12 (2024): 1. https://doi.org/10.1111/1440-1681.70003.
MLA (9th ed.) CitationLin, Tingting, et al. "GLP‐1 Receptor Agonist Liraglutide Alleviates Kidney Injury by Regulating Nuclear Translocation of NRF2 in Diabetic Nephropathy." Clinical & Experimental Pharmacology & Physiology, vol. 51, no. 12, 2024, p. 1, https://doi.org/10.1111/1440-1681.70003.